Nordic Bioscience Clinical Development

Nordic Bioscience Clinical Development (NBCD) is a specialized Contract Research Organization (CRO) that leverages proprietary biomarker technology to optimize clinical drug development. The company focuses on chronic diseases characterized by extracellular matrix (ECM) remodeling, such as osteoarthritis, fibrosis, and cardiovascular disorders. By integrating high-precision biochemical markers into clinical trial design, NBCD helps pharmaceutical partners identify the most responsive patient populations and demonstrate early efficacy. Their services span from regulatory strategy and trial management to advanced data analytics and biomarker validation. Headquartered in Denmark, NBCD is recognized for its expertise in "fast-to-proof-of-concept" clinical programs.